What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- COPD
Marc Miravitlles spends much of his time researching COPD, Internal medicine, Physical therapy, Intensive care medicine and Exacerbation.
The study incorporates disciplines such as Pulmonary disease, Quality of life, Disease, Severity of illness and Spirometry in addition to COPD.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Sputum, Surgery and Pathology.
His Physical therapy research incorporates elements of Cross-sectional study, Respiratory disease, Obstructive lung disease and Quality of life.
He has included themes like Chronic bronchitis, Asthma, Cohort and Emergency medicine in his Intensive care medicine study.
His Exacerbation study combines topics in areas such as Ambulatory and Salmeterol.
His most cited work include:
- Chronic obstructive pulmonary disease (681 citations)
- Outcomes for COPD pharmacological trials: From lung function to biomarkers (654 citations)
- Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. (624 citations)
What are the main themes of his work throughout his whole career to date?
COPD, Internal medicine, Intensive care medicine, Physical therapy and Pulmonary disease are his primary areas of study.
His COPD study combines topics from a wide range of disciplines, such as Exacerbation, Quality of life, Asthma, Disease and Pediatrics.
His work on Chronic bronchitis, Observational study and Spirometry as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
His biological study spans a wide range of topics, including Moxifloxacin and Bronchitis.
His Intensive care medicine study integrates concerns from other disciplines, such as Antibiotics and Clinical trial.
The study incorporates disciplines such as Severity of illness and Epidemiology in addition to Physical therapy.
He most often published in these fields:
- COPD (58.57%)
- Internal medicine (37.45%)
- Intensive care medicine (22.77%)
What were the highlights of his more recent work (between 2017-2021)?
- COPD (58.57%)
- Internal medicine (37.45%)
- Intensive care medicine (22.77%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Exacerbation.
His study in the field of Obstructive lung disease also crosses realms of In patient.
His studies link Gastroenterology with Internal medicine.
His research in Intensive care medicine intersects with topics in Clinical trial, Bronchiectasis, Quality of life, Guideline and Inhaled corticosteroids.
His work deals with themes such as Body mass index, Multivariate analysis, Emergency medicine, Hazard ratio and Bronchodilator, which intersect with Exacerbation.
The concepts of his Asthma study are interwoven with issues in Eosinophilia, Chronic bronchitis and Asthma copd overlap.
Between 2017 and 2021, his most popular works were:
- The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. (48 citations)
- Alpha-1 antitrypsin deficiency: outstanding questions and future directions (32 citations)
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges. (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- COPD
His primary scientific interests are in COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Exacerbation.
His COPD research integrates issues from Spirometry, Asthma, Eosinophilia and Disease.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Alpha and Genetic data.
His Intensive care medicine research is multidisciplinary, relying on both Inhaled corticosteroids, Clinical research, Guideline and Quality of life.
His Pulmonary disease research is multidisciplinary, incorporating elements of Respiratory Medicine, Mechanical ventilation, Primary care, Pulmonary function testing and Interstitial lung disease.
His Exacerbation research is multidisciplinary, incorporating perspectives in Likert scale, Predictive value, Mean age and Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
